EP Patent

EP4407354A2 — Ws12-releasing contact lens

Assigned to CooperVision International Ltd · Expires 2024-07-31 · 2y expired

What this patent protects

A WS12-releasing contact lens is described as well as method of manufacturing the same. The WS12-releasing contact lens comprises a polymeric lens body and 0.25 µg to 10.0 µg WS12 releasably adhered to the polymeric lens body. The WS12-releasing contact lens can be comfortably wo…

USPTO Abstract

A WS12-releasing contact lens is described as well as method of manufacturing the same. The WS12-releasing contact lens comprises a polymeric lens body and 0.25 µg to 10.0 µg WS12 releasably adhered to the polymeric lens body. The WS12-releasing contact lens can be comfortably worn by a symptomatic contact lens wearer and can increase the duration of comfortable lens wearing time and/or reduce lens awareness events and/or reduce contact lens dryness in a symptomatic contact lens wearer.

Drugs covered by this patent

Patent Metadata

Patent number
EP4407354A2
Jurisdiction
EP
Classification
—
Expires
2024-07-31
Drug substance claim
No
Drug product claim
No
Assignee
CooperVision International Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.